bezafibrate has been researched along with Hypertriglyceridemia in 87 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.15) | 18.7374 |
| 1990's | 26 (29.89) | 18.2507 |
| 2000's | 38 (43.68) | 29.6817 |
| 2010's | 19 (21.84) | 24.3611 |
| 2020's | 3 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, H; Kagaya, Y; Kanazawa, M; Kondo, M; Miura, M; Nakamura, A; Saito, H; Sato, K | 1 |
| Fukuda, H; Iwasaki, M; Koshida, T; Matsuzaki, K; Saito, M; Suzuki, H; Suzuki, Y; Takahara, H; Umezawa, Y | 1 |
| Akai, M; Emoto, M; Fukuda, Y; Hasegawa, T; Hayakawa, Y; Horio, T; Imanishi, M; Nishida, M; Tateishi, Y | 1 |
| Abe, M; Fukuda, N; Haketa, A; Hatanaka, Y; Kobayashi, H; Nakamura, Y; Soma, M; Tanaka, S; Tsunemi, A; Ueno, T | 1 |
| Avari, P; Cegla, J; Meeran, K; Samarasinghe, S | 1 |
| Imamura, H; Kawana, H; Nagayama, D; Nakamura, S; Ohira, M; Oka, R; Saiki, A; Sato, Y; Shimizu, N; Shirai, K; Tanaka, S; Tatsuno, I; Watanabe, Y; Yamaguchi, T | 1 |
| Araújo, RS; Borges, Mde A; Ramos, Ade P | 1 |
| Ito, H; Kohno, K; Miyoshi, T; Morita, H; Nakamura, K; Noda, Y; Oe, H; Ohno, Y; Toh, N | 1 |
| Oliveira, HC; Patrício, PR; Raposo, HF; Simões, MC | 1 |
| Hao, Z; Liu, B; Liu, M; Tao, W; Wang, D | 1 |
| Arbel, Y; Benzekry, S; Erez, A; Fisman, EZ; Goldenberg, I; Klempfner, R; Shlomo, N; Tenenbaum, A | 1 |
| Erez, A; Fisman, E; Goldenberg, I; Israel, A; Klempfner, R; Kopel, E; Sagit, BZ; Shlomo, N; Tenenbaum, A | 1 |
| Orphanos, GS; Picolos, MK; Stavrou, NG | 1 |
| Kotani, K; Satoh, N; Yamada, T | 1 |
| Cunnane, SC; Fortier, M; Lorrain, D; Plourde, M; Tessier, D; Tremblay-Mercier, J | 1 |
| Gdula-Dymek, A; Krysiak, R; Okopien, B | 5 |
| Krysiak, R; Okopien, B | 1 |
| Banerjee, I; Diacono, D; Fagbemi, A; Puleston, J | 1 |
| Biemond, I; Boverhof, R; Hollum, ME; Jonkers, IJ; Kuipers, F; Lamers, CH; Ledeboer, M; Masclee, AA; Meinders, AE; Smelt, AH; Stellaard, F | 1 |
| Hosoi, T; Ito, H; Kazama, H; Okazaki, M; Orimo, H; Usui, S | 1 |
| Fujioka, Y; Iwasaki, T; Masai, M; Morimoto, S; Ohyanagi, M; Okumura, T; Tsuboi, S; Tsujino, T | 1 |
| de Man, FH; Hattori, H; Jonkers, IJ; Scheek, LM; Smelt, AH; van der Laarse, A; van Gent, T; van Tol, A | 1 |
| Dobordzhginidze, LM; Gratsianskiĭ, NA | 1 |
| Kiniwa, M; Matsuura, N; Ohmori, K; Yamada, H; Yamamoto, A; Yasuda, A | 1 |
| Fang, CC; Lee, YT; Su, TC; Yang, KC | 1 |
| Ikewaki, K; Kido, T; Mochizuki, S; Noma, K; Tohyama, J | 1 |
| Bulut, D; Bulut-Streich, N; Graf, C; Hanefeld, C; Mügge, A; Spiecker, M | 1 |
| Duriez, P; Fruchart, JC | 2 |
| Boverhof, R; Jonkers, IJ; Kuipers, F; Masclee, AA; Princen, HM; Romijn, JA; Smelt, AH; Stellaard, F | 1 |
| Battler, A; Behar, S; Benderly, M; Boyko, V; Goldbourt, U; Goldenberg, I; Haim, M; Tanne, D | 1 |
| Nosaka, S; Sakuma, K; Ushiroyama, T | 1 |
| Ayaori, M; Fayad, ZA; Kihara, T; Kusuhara, M; Momiyama, Y; Nagata, M; Nakamura, H; Nakaya, K; Ogura, M; Ohmori, R; Ohsuzu, F; Sawada, S; Tanaka, N; Taniguchi, H; Yonemura, A | 1 |
| Ebihara, Y; Fox, JC; Saito, Y; Sasaki, J; Shirai, K; Yamada, N; Yanase, T | 1 |
| de Souza, ME; Delatim, FC; Geraix, J; Pereira, PC | 1 |
| Fava, S; Frendo, M; Theuma, R | 1 |
| Nagao, M; Oikawa, S | 1 |
| Brunner, D; Schwartz, S; Waysbort, J | 1 |
| Fukamachi, I; Hashimoto, H; Kobayashi, J; Niihara, K; Saito, Y; Sasaki, N; Shirai, K; Takahashi, K; Tashiro, J; Yoshida, S | 1 |
| Arnon, R; Eisenberg, S; Sehayek, E | 1 |
| Shepherd, J | 1 |
| Bar-David, J; Ielig, I; Leiberman, JR; Maislos, M; Mazor, M | 1 |
| Auerbach, BJ; Barnett, BC; Bisgaier, CL; Bousley, R; Essenburg, AD; Kieft, KA; Krause, BR; Newton, RS; Stanfield, R | 1 |
| Båvenholm, P; de Faire, U; Ericsson, CG; Godsland, I; Hamsten, A; Jovinge, S; Nilsson, J; Proudler, A; Tornvall, P | 1 |
| Sterna, R | 1 |
| Heras, M; La Ville, AE; Masana, L; Motta, C; Plana, N; Ribalta, J; Solà, R | 1 |
| Kesäniemi, YA | 1 |
| Charach, G; Grosskopf, I; Weintraub, MS | 1 |
| Rader, DJ | 1 |
| Dierkes, J; Luley, C; Westphal, S | 1 |
| Mooney, A | 1 |
| de Man, FH; Jonkers, IJ; Onkenhout, W; Smelt, AH; van der Laarse, A | 1 |
| Miyake, Y; Toyota, Y; Yamamoto, A; Yamamura, T | 1 |
| Richey, JM; Si, X; Webb, RC | 1 |
| de Man, FH; Mohrschladt, MF; Smelt, AH; Stoeken, DJ; Sturk, A; Westendorp, RG; Weverling-Rijnsburger, AW | 1 |
| Hannak, M; Lüscher, TF; Noll, G; Spieker, LE | 1 |
| Boschetti, C; Cofrancesco, E; Cortellaro, F; Cortellaro, M; Mancini, M; Mariani, M; Paoletti, R | 1 |
| Doi, K; Fukushima, M; Nagasaka, S; Nagata, I; Nakai, Y; Sakai, M; Taniguchi, A; Tokuyama, K | 1 |
| de Man, FH; Gevers Leuven, JA; Nieuwland, R; Romijn, F; Smelt, AH; Sturk, A; van der Laarse, A | 1 |
| Ito, Y; Miyashita, Y; Murano, T; Shirai, K; Totsuka, M; Watanabe, H | 1 |
| Inano, K; Kashiwa, T; Miida, T; Murakami, T; Nakamura, Y; Okada, M; Ozaki, K; Sakai, K; Tsuda, T; Yamaguchi, T | 1 |
| Buytenhek, R; de Man, FH; Jonkers, IJ; Leuven, JA; Onkenhout, W; Princen, HM; Schwedhelm, E; Smelt, AH; Troost, R; van Der Laarse, A; van Duyvenvoorde, W | 1 |
| Faergeman, O | 1 |
| Higashio, S; Ikeda, A; Ueki, M; Ushiroyama, T | 1 |
| Rubins, HB | 1 |
| de Beer, F; de Man, FH; Fruchart, JC; Havekes, LM; Jansen, H; Leuven, JA; Schoormans, SC; Smelt, AH; Souverijn, JH; van der Laarse, A; Vroom, TF | 1 |
| Grassi, G; Taddei, S | 1 |
| Blauw, GJ; de Man, FH; Frölich, M; Gevers Leuven, JA; Jonkers, IJ; Kamper, AM; Smelt, AH; van der Laarse, A | 1 |
| Harano, Y; Ikebuchi, M; Norioka, M; Ryomoto, K; Suzuki, M | 1 |
| Chiodo, F; Manfredi, R | 1 |
| Bertina, RM; de Man, FH; Jonkers, IJ; Sandset, PM; Smelt, AH; van der Laarse, A; van Tilburg, NH | 1 |
| Jonkers, IJ; Mohrschladt, MF; Smelt, AH; van der Laarse, A; Westendorp, RG | 1 |
| Hattori, A; Iguchi, A; Kuzuya, M; Muraguchi, M; Nakamura, J; Ohmoto, Y; Tamaya, N; Ueda, M; Uemura, K; Yoshioka, S | 1 |
| Yamada, N | 1 |
| Franceschini, G; Gianfranceschi, G; Maderna, P; Mannucci, L; Mussoni, L; Pazzucconi, F; Sirtori, CR; Tremoli, E; Werba, P | 1 |
| Avogaro, P; Bittolo Bon, G; Ghiselli, G; Soldan, S | 1 |
| Anderson, DC; Arrol, S; Bhatagnar, D; Durrington, PN; Ishola, M; Mackness, M; Winocour, PH | 1 |
| Bihain, BE; Grant, AM; Mann, CJ; Yen, FT | 1 |
| Capra, C; Frisoni, R; Gualandi, F; Malfanti, L; Occhini, D; Valbonesi, M | 1 |
| Frishman, WH; Kahn, S; Zimetbaum, P | 1 |
| Chan, MK | 1 |
| Lithell, H; Vessby, B | 1 |
| Kłosiewicz-Latoszek, L; Mirkiewicz, E; Naruszewicz, M | 1 |
16 review(s) available for bezafibrate and Hypertriglyceridemia
| Article | Year |
|---|---|
Management of hypertriglyceridaemic pancreatitis in the acute setting and review of literature.
Topics: Acute Disease; Administration, Intravenous; Adult; Bezafibrate; Humans; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Male; Pancreatitis; Plasma Exchange; Treatment Outcome; Triglycerides | 2018 |
Fibrates for secondary prevention of cardiovascular disease and stroke.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Bezafibrate; Cardiovascular Diseases; Cause of Death; Cholesterol, HDL; Clofibrate; Coronary Disease; Female; Fenofibrate; Fibric Acids; Gemfibrozil; Humans; Hypertriglyceridemia; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2015 |
[Fibrates: mechanism of action, effect on levels of lipids and lipoproteins, risk of coronary events. Part 1. Clofibrate, gemfibrosil, besafibrate].
Topics: Bezafibrate; Clofibrate; Female; Gemfibrozil; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Male; Randomized Controlled Trials as Topic | 2004 |
Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.
Topics: Animals; Anticholesteremic Agents; Atherosclerosis; Bezafibrate; Biological Transport; Cholesterol, HDL; Clofibric Acid; Coronary Artery Disease; Fenofibrate; Gemfibrozil; Humans; Hypercholesterolemia; Hypertriglyceridemia; Hypolipidemic Agents; Liver; PPAR alpha; Randomized Controlled Trials as Topic; Triglycerides | 2006 |
[Intervention for hypertriglyceridemia].
Topics: Aged; Bezafibrate; Clofibric Acid; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Humans; Hypertriglyceridemia; Male; Middle Aged; Niacin | 2007 |
Mechanism of action of fibrates.
Topics: Apolipoproteins B; Bezafibrate; Clofibric Acid; Female; Fenofibrate; Fibric Acids; Gemfibrozil; Humans; Hypercholesterolemia; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins, LDL; Male; Receptors, LDL | 1993 |
Serum triglycerides and clinical benefit in lipid-lowering trials.
Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol, LDL; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Estrogen Replacement Therapy; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Myocardial Infarction; Myocardial Ischemia; Postmenopause; Pravastatin; Risk Factors; Simvastatin; Triglycerides | 1998 |
Pathophysiology and management of low high-density lipoprotein cholesterol.
Topics: Animals; Bezafibrate; Cholesterol, HDL; Coronary Disease; Diet; Female; Humans; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents; Life Style; Lipoproteins, HDL; Male; Middle Aged; Risk Factors | 1999 |
Treating patients with hypertriglyceridaemia saves lives: triglyceride revisited.
Topics: Arteriosclerosis; Bezafibrate; Clinical Trials as Topic; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Risk Factors; Triglycerides | 1999 |
Hypertriglyceridemia and the fibrate trials.
Topics: Bezafibrate; Cardiovascular Diseases; Clinical Trials as Topic; Female; Gemfibrozil; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Lipoproteins, HDL; Male; Risk; Triglycerides | 2000 |
Recent developments in the treatment of hypertriglyceridemia.
Topics: Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Fatty Acids, Omega-3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents | 1999 |
Triglycerides and coronary heart disease: implications of recent clinical trials.
Topics: Aged; Bezafibrate; Controlled Clinical Trials as Topic; Coronary Artery Disease; Female; Gemfibrozil; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Middle Aged; Prognosis; Treatment Outcome; Triglycerides | 2000 |
Antihypertensive mechanisms of lipid-lowering drugs: decoding the Rosetta stone's inscriptions'.
Topics: Antihypertensive Agents; Bezafibrate; Humans; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents | 2001 |
Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.
Topics: Bezafibrate; HIV Infections; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents; Indinavir; Lipids; Retrospective Studies; Ritonavir; Saquinavir | 2001 |
[Fibrates].
Topics: Bezafibrate; Fenofibrate; Humans; Hypertriglyceridemia; Hypolipidemic Agents | 2002 |
Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins.
Topics: Bezafibrate; Cholesterol, HDL; Clofibric Acid; Diabetes Mellitus, Type 2; Fenofibrate; Fibric Acids; Gemfibrozil; Humans; Hypercholesterolemia; Hypertriglyceridemia; Hypolipidemic Agents; Kidney Diseases; Lipoproteins, VLDL; Metabolic Clearance Rate; Triglycerides | 1991 |
37 trial(s) available for bezafibrate and Hypertriglyceridemia
| Article | Year |
|---|---|
Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study.
Topics: Adult; Aged; Apolipoprotein A-I; Benzoxazoles; Bezafibrate; Butyrates; Cholesterol, HDL; Cross-Over Studies; Female; Humans; Hypertriglyceridemia; Male; Middle Aged; Peroxisome Proliferator-Activated Receptors; Treatment Outcome; Triglycerides | 2023 |
Bezafibrate Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Hypertriglyceridemic Patients with Type 2 Diabetes Mellitus.
Topics: Aged; Ankle; Ankle Brachial Index; Atherosclerosis; Bezafibrate; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Oxidative Stress; Risk Factors; Triglycerides; Vascular Stiffness | 2019 |
Bezafibrate improves postprandial hypertriglyceridemia and associated endothelial dysfunction in patients with metabolic syndrome: a randomized crossover study.
Topics: Adult; Bezafibrate; Cross-Over Studies; Endothelium, Vascular; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Metabolic Syndrome; Middle Aged; Postprandial Period; Single-Blind Method | 2014 |
Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial.
Topics: Aged; Bezafibrate; Biomarkers; Chi-Square Distribution; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Intention to Treat Analysis; Israel; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Registries; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Triglycerides | 2016 |
Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry.
Topics: Aged; Bezafibrate; Biomarkers; Chi-Square Distribution; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Registries; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Triglycerides; Up-Regulation | 2016 |
Bezafibrate mildly stimulates ketogenesis and fatty acid metabolism in hypertriglyceridemic subjects.
Topics: Aged; Bezafibrate; Breath Tests; Fasting; Fatty Acids; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Ketone Bodies; Liver; Male; Oxidation-Reduction; Triglycerides | 2010 |
Monocyte-suppressing effect of bezafibrate but not omega-3 fatty acids in patients with isolated hypertriglyceridaemia.
Topics: Bezafibrate; C-Reactive Protein; Cytokines; Fatty Acids, Omega-3; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Inflammation; Insulin Resistance; Male; Middle Aged; Monocytes | 2011 |
The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia.
Topics: Adult; Aged; Bezafibrate; C-Reactive Protein; Cholesterol; Cytokines; Fatty Acids, Omega-3; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Inflammation; Lymphocytes; Male; Middle Aged; Treatment Outcome; Triglycerides | 2011 |
Hemostatic effects of bezafibrate and ω-3 fatty acids in isolated hypertriglyceridemic patients.
Topics: Bezafibrate; Blood Glucose; Fatty Acids, Omega-3; Female; Hemostasis; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Insulin Resistance; Lipid Metabolism; Male; Middle Aged | 2011 |
Omega-3 fatty acids enhance monocyte-suppressing effect of bezafibrate in patients with isolated hypertriglyceridemia.
Topics: Adult; Aged; Bezafibrate; Cytokines; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Middle Aged; Monocytes | 2012 |
Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil.
Topics: Analysis of Variance; Bezafibrate; Bile; Case-Control Studies; Cholecystokinin; Cholelithiasis; Cholesterol; Cross-Over Studies; Fish Oils; Gallbladder; Gallbladder Emptying; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipids; Male; Risk; Statistics, Nonparametric; Ultrasonography | 2003 |
Effects of bezafibrate and pravastatin on remnant-like lipoprotein particles and lipoprotein subclasses in type 2 diabetes.
Topics: Aged; Aged, 80 and over; Bezafibrate; Cholesterol; Chromatography, High Pressure Liquid; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Triglycerides | 2003 |
Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy.
Topics: Adrenergic beta-Antagonists; Adult; Bezafibrate; Blood Glucose; Carrier Proteins; Cholesterol Esters; Cholesterol, HDL; Cross-Over Studies; Data Interpretation, Statistical; Double-Blind Method; Female; Humans; Hypertriglyceridemia; Insulin; Insulin Resistance; Linear Models; Male; Membrane Proteins; Middle Aged; Molecular Weight; Phospholipid Transfer Proteins | 2003 |
Fish oil increases bile acid synthesis in male patients with hypertriglyceridemia.
Topics: Bezafibrate; Bile Acids and Salts; Blood Glucose; Body Mass Index; Chenodeoxycholic Acid; Cholesterol; Cholic Acid; Clofibric Acid; Cross-Over Studies; Fasting; Fish Oils; Gallstones; Humans; Hypertriglyceridemia; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Triglycerides | 2006 |
Decrease in triglyceride level by bezafibrate is related to reduction of recurrent coronary events: a Bezafibrate Infarction Prevention substudy.
Topics: Aged; Bezafibrate; Clofibric Acid; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors; Secondary Prevention; Triglycerides | 2006 |
Effects of bezafibrate on HDL2/HDL3 ratio in postmenopausal hypertriglyceridemic women.
Topics: Bezafibrate; Cholesterol; Female; Humans; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins, HDL; Middle Aged; Postmenopause | 2006 |
Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia.
Topics: Aged; Aorta; Atherosclerosis; Bezafibrate; Diffusion Magnetic Resonance Imaging; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Magnetic Resonance Angiography; Male; Middle Aged; Prospective Studies | 2008 |
Effect of rosuvastatin 5-20mg on triglycerides and other lipid parameters in Japanese patients with hypertriglyceridemia.
Topics: Apolipoproteins; Bezafibrate; Cholesterol; Dose-Response Relationship, Drug; Double-Blind Method; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents; Japan; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triglycerides | 2007 |
Effect of bezafibrate on lipids, lipoproteins, apolipoproteins and platelet aggregation in hypertriglyceridemic patients.
Topics: Adenosine Diphosphate; Adult; Aged; Apolipoproteins; Bezafibrate; Cholesterol, HDL; Double-Blind Method; Female; Humans; Hypertriglyceridemia; Lipids; Lipoproteins; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Triglycerides | 1994 |
Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease.
Topics: Bezafibrate; Blood Glucose; Body Weight; Cholesterol; Coronary Artery Disease; Coronary Disease; Glucose; Homeostasis; Humans; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Insulin Resistance; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Risk Factors; Triglycerides; Tumor Necrosis Factor-alpha | 1998 |
[The effect of hypolipemic treatment on the pharmacokinetics of propranolol].
Topics: Administration, Oral; Anticholesteremic Agents; Bezafibrate; Chromatography, High Pressure Liquid; Drug Interactions; Female; Humans; Hydroxylation; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents; Lovastatin; Male; Phenotype; Propranolol; Triglycerides | 1997 |
Effects of fibric acid derivatives and metformin on postprandial lipemia.
Topics: Bezafibrate; Chylomicrons; Gemfibrozil; Glucose Tolerance Test; Humans; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Lipoproteins, HDL; Male; Metformin; Middle Aged; Postprandial Period | 1998 |
Serum homocysteine increases after therapy with fenofibrate or bezafibrate.
Topics: Adult; Bezafibrate; Chromatography, High Pressure Liquid; Fenofibrate; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; Hypertriglyceridemia; Hypolipidemic Agents; Male; Middle Aged; Pilot Projects; Pyridoxine; Vitamin B 12 | 1999 |
Implication of fibrate therapy for homocysteine.
Topics: Bezafibrate; Creatinine; Cross-Over Studies; Double-Blind Method; Female; Homocysteine; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipids; Male | 1999 |
Hyperlipoproteinemia affects cytokine production in whole blood samples ex vivo. The influence of lipid-lowering therapy.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Atorvastatin; Bezafibrate; Cross-Over Studies; Cytokines; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Male; Middle Aged; Pyrroles; Reference Values | 2000 |
Efficacy and tolerability of fluvastatin and bezafibrate in patients with hyperlipidemia and persistently high triglyceride levels.
Topics: Adult; Aged; Bezafibrate; Cholesterol; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents; Indoles; Male; Middle Aged | 2000 |
Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination Trea
Topics: Adult; Aged; Bezafibrate; C-Reactive Protein; Cholesterol, LDL; Coronary Disease; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fibrinogen; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Hypertriglyceridemia; Hypolipidemic Agents; Indoles; Male; Middle Aged; Tissue Plasminogen Activator; Treatment Outcome | 2000 |
Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients.
Topics: Asian People; Bezafibrate; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Japan; Male; Middle Aged | 2000 |
Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy.
Topics: Antigens, CD; Bezafibrate; Blood Platelets; Cholesterol; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Flow Cytometry; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Membrane Glycoproteins; Tetraspanin 30; Triglycerides | 2000 |
Normal oxidative stress and enhanced lipoprotein resistance to in vitro oxidation in hypertriglyceridemia: effects of bezafibrate therapy.
Topics: Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Dinoprost; Double-Blind Method; Female; Humans; Hypertriglyceridemia; In Vitro Techniques; Lipid Metabolism; Lipids; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress | 2000 |
Coagulofibrinolytic assessment of effects of bezafibrate on hypertriglyceridemia in postmenopausal women.
Topics: Bezafibrate; Female; Fibrinolysis; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Middle Aged; Postmenopause | 2000 |
The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding.
Topics: Adult; Bezafibrate; Double-Blind Method; Enzyme Activation; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipolysis; Lipoprotein Lipase; Lipoproteins, VLDL; Male; Middle Aged; Receptors, LDL; Substrate Specificity; Up-Regulation | 2000 |
Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia.
Topics: Absorption; Adult; Bezafibrate; Blood Pressure; Cyclic GMP; Double-Blind Method; Fatty Acids, Nonesterified; Female; Heart Rate; Hemodynamics; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Kidney; Lipids; Male; Middle Aged; Sodium; Sympathetic Nervous System | 2001 |
Alterations in the extrinsic pathway in hypertriglyceridemia do not cause a 'procoagulant state': effects of bezafibrate therapy.
Topics: Adult; Antigens; Bezafibrate; Blood Coagulation Factors; Factor VII; Factor VIIa; Female; Hemostasis; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Thrombophilia | 2001 |
Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial.
Topics: Bezafibrate; Blood Glucose; C-Reactive Protein; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Humans; Hypertriglyceridemia; Hypolipidemic Agents; In Vitro Techniques; Inflammation; Inflammation Mediators; Insulin; Insulin Resistance; Interleukin-6; Lipids; Male; Middle Aged; Tumor Necrosis Factor-alpha | 2002 |
Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemia.
Topics: Adult; Aged; Bezafibrate; Female; Fibrinogen; Fibrinolysis; Humans; Hypertriglyceridemia; Lipids; Lipoproteins; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Tissue Plasminogen Activator | 1992 |
The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemia.
Topics: Adolescent; Adult; Aged; Bezafibrate; Cholesterol; Diabetes Mellitus, Type 1; Double-Blind Method; Humans; Hypercholesterolemia; Hypertriglyceridemia; Lipoproteins; Lipoproteins, IDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Triglycerides | 1992 |
34 other study(ies) available for bezafibrate and Hypertriglyceridemia
| Article | Year |
|---|---|
Efficacy and safety of pemafibrate in patients with chronic kidney disease: A retrospective study.
Topics: Bezafibrate; Drug Substitution; Fenofibrate; Humans; Hypertriglyceridemia; Renal Insufficiency; Renal Insufficiency, Chronic; Retrospective Studies | 2023 |
Differential effects on renal function and glucose metabolism of renal dependent bezafibrate and non-renal dependent pemafibrate in patients with hypertriglyceridemia.
Topics: Bezafibrate; Blood Glucose; Creatinine; Fibric Acids; Glucose; Glycated Hemoglobin; Humans; Hypertriglyceridemia; Kidney; Triglycerides | 2023 |
Lipoprotein Lipase Deficiency Arising in Type V Dyslipidemia.
Topics: Adult; Age of Onset; Bezafibrate; Diabetes Complications; Ezetimibe; Genetic Variation; Heterozygote; Humans; Hyperlipoproteinemia Type I; Hypertriglyceridemia; Hypolipidemic Agents; Insulin Resistance; Lipoprotein Lipase; Male | 2019 |
[Bezafibrate in an infant with congenital generalized lipodystrophy and severe hypertriglyceridemia].
Topics: Bezafibrate; Growth Charts; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Infant; Lipodystrophy, Congenital Generalized; Male | 2013 |
Fibrates and fish oil, but not corn oil, up-regulate the expression of the cholesteryl ester transfer protein (CETP) gene.
Topics: Animals; Bezafibrate; Cholesterol Ester Transfer Proteins; Combined Modality Therapy; Corn Oil; Crosses, Genetic; Dietary Supplements; Female; Fenofibrate; Fibric Acids; Fish Oils; Gemfibrozil; Hypertriglyceridemia; Hypolipidemic Agents; Liver; Male; Mice, Transgenic; Random Allocation; RNA, Messenger; Up-Regulation | 2014 |
Hypertriglyceridemia: An underdiagnosed side effect of Capecitabine chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Bezafibrate; Capecitabine; Cecum; Deoxycytidine; Fluorouracil; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Intestinal Neoplasms; Male; Middle Aged; Neoplasm Staging | 2010 |
Bezafibrate and serum amyloid A--low-density lipoprotein complex in patients with type 2 diabetes mellitus and hypertriglyceridemia.
Topics: Bezafibrate; Diabetes Mellitus, Type 2; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Serum Amyloid A Protein; Triglycerides | 2010 |
Lymphocyte-suppressing effects of omega-3 fatty acids in bezafibrate-treated patients with isolated hypertriglyceridemia.
Topics: Bezafibrate; Cytokines; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lymphocytes; Male | 2012 |
Hemostatic effects of omega-3 fatty acids in isolated hypertriglyceridemic patients treated with bezafibrate.
Topics: Adult; Aged; Antigens; Bezafibrate; Drug Therapy, Combination; Factor VII; Fatty Acids, Omega-3; Female; Fibrinogen; Hemostasis; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Middle Aged; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Prothrombin Time; von Willebrand Factor | 2012 |
Bezafibrate to prevent relapsing pancreatitis in WAGR syndrome.
Topics: Bezafibrate; Child; Combined Modality Therapy; Diet, Fat-Restricted; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Pancreatitis, Acute Necrotizing; Prognosis; Secondary Prevention; WAGR Syndrome | 2012 |
Troglitazone reduces activity of the Na+/H+ exchanger in fructose-fed borderline hypertensive rats.
Topics: Animals; Bezafibrate; Blood Glucose; Blood Platelets; Blood Pressure; Calcium; Chromans; Diet; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Fructose; Hydrogen-Ion Concentration; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Male; Propionates; Rats; Sodium-Hydrogen Exchangers; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone; Vasodilator Agents | 2003 |
Effects of a novel anti-hyperlipidemic agent, S-2E, on blood lipid levels in rats with fructose-induced hypertriglyceridemia.
Topics: Animals; Benzoates; Bezafibrate; Cholesterol; Cholesterol, HDL; Diet; Fructose; Hydroxybenzoate Ethers; Hypertriglyceridemia; Hypolipidemic Agents; Insulin Resistance; Lipid Metabolism; Lipids; Liver; Male; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Triglycerides | 2004 |
Treatment of fibrate-induced rhabdomyolysis with plasma exchange in ESRD.
Topics: Bezafibrate; Combined Modality Therapy; Female; Glomerulonephritis; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Kidney Failure, Chronic; Middle Aged; Plasma Exchange; Renal Dialysis; Rhabdomyolysis | 2005 |
Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia--a nuclear magnetic resonance study.
Topics: Bezafibrate; Body Mass Index; C-Reactive Protein; Chemokine CCL2; Cholesterol, HDL; Cholesterol, VLDL; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Inflammation; Interleukin-6; Lipoproteins; Lipoproteins, HDL; Lipoproteins, HDL3; Lipoproteins, LDL; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nephelometry and Turbidimetry; Risk Factors; Triglycerides | 2005 |
Comparison of endothelial function in patients with metabolic syndrome on bezafibrate or atorvastatin therapy.
Topics: Aged; Atorvastatin; Bezafibrate; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Coronary Circulation; Endothelium, Vascular; Forearm; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents; Male; Metabolic Syndrome; Middle Aged; Pyrroles; Regional Blood Flow; Treatment Outcome; Vasodilation | 2005 |
Bezafibrate for the treatment of hypertriglyceridemia in HIV1-infected patients on highly active antiretroviral therapy.
Topics: Adult; Antiretroviral Therapy, Highly Active; Bezafibrate; CD4-CD8 Ratio; Female; HIV Infections; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Treatment Outcome; Viral Load | 2006 |
Delayed bezafibrate-induced angio-oedema in a 68-year-old man.
Topics: Aged; Angioedema; Bezafibrate; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male | 2007 |
Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
Topics: Adult; Aged; Bezafibrate; Blood Glucose; Female; Glucose Intolerance; Humans; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Immunoenzyme Techniques; Insulin; Lipase; Lipoprotein Lipase; Liver; Male; Middle Aged; Triglycerides | 1994 |
Disparate effects of a triglyceride lowering diet and of bezafibrate on the HDL system: a study in patients with hypertriglyceridaemia and low HDL-cholesterol levels.
Topics: Bezafibrate; Cholesterol, HDL; Combined Modality Therapy; Female; Humans; Hypertriglyceridemia; Lipoprotein Lipase; Male; Middle Aged; Triglycerides | 1993 |
Gestational diabetes complicated by severe hypertriglyceridemia and acute pancreatitis.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Bezafibrate; Combined Modality Therapy; Female; Humans; Hypertriglyceridemia; Infant, Newborn; Insulin; Male; Pancreatitis; Parenteral Nutrition, Total; Pregnancy; Pregnancy Complications; Pregnancy in Diabetics; Respiratory Distress Syndrome; Systemic Inflammatory Response Syndrome | 1996 |
Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic rats.
Topics: Animals; Apolipoproteins B; Apolipoproteins E; Bezafibrate; Body Weight; Cholesterol; Cholesterol, LDL; Dose-Response Relationship, Drug; Gemfibrozil; Hypertriglyceridemia; Hypolipidemic Agents; Immunoelectrophoresis; Lipoprotein Lipase; Liver; Male; Rats; Rats, Sprague-Dawley; Spectrophotometry; Triglycerides | 1996 |
Physicochemical changes in HDL3 after bezafibrate treatment: influence on free cholesterol efflux from human fibroblasts.
Topics: Adult; Bezafibrate; Cells, Cultured; Fibroblasts; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Lipoproteins, HDL; Lipoproteins, HDL3; Male; Middle Aged; Skin | 1997 |
Low density lipoprotein (LDL) binding affinity for the LDL receptor in hyperlipoproteinemia.
Topics: Adult; Bezafibrate; Female; Humans; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Male; Middle Aged; Particle Size; Probucol; Receptors, LDL | 1999 |
Bezafibrate, an anti-hypertriglyceridemic drug, attenuates vascular hyperresponsiveness and elevated blood pressure in fructose-induced hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Bezafibrate; Blood Pressure; Body Weight; Calcium Channel Agonists; Dose-Response Relationship, Drug; Fructose; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; In Vitro Techniques; Lipoproteins, VLDL; Male; Rats; Rats, Sprague-Dawley; Vasoconstriction | 1999 |
Enhancement of preheparin serum lipoprotein lipase mass by bezafibrate administration.
Topics: Bezafibrate; Drug Administration Schedule; Electrophoresis, Gel, Two-Dimensional; Enzyme-Linked Immunosorbent Assay; Humans; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents; Lipids; Lipoprotein Lipase; Lipoproteins | 2000 |
Bezafibrate increases prebeta 1-HDL at the expense of HDL2b in hypertriglyceridemia.
Topics: Adult; Bezafibrate; Carrier Proteins; Cholesterol Ester Transfer Proteins; Enzyme Activation; Female; Glycoproteins; High-Density Lipoproteins, Pre-beta; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipase; Lipoproteins, HDL; Lipoproteins, HDL2; Male; Middle Aged; Molecular Weight; Phosphatidylcholine-Sterol O-Acyltransferase; Triglycerides | 2000 |
Effect of bezafibrate treatment on the altered lipoprotein profiles in hypertriglyceridemic subjects.
Topics: Apolipoproteins B; Bezafibrate; Cholesterol; Cholesterol, VLDL; Humans; Hyperlipoproteinemia Type IV; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Lipoproteins, VLDL; Triglycerides | 2000 |
Noninvolvement of hypertriglyceridemia and hyperleptinemia in blood pressure increases induced by dietary lard in rats.
Topics: Adipose Tissue; Animals; Bezafibrate; Blood Glucose; Blood Pressure; Cholesterol; Diet; Dietary Fats; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Leptin; Male; Rats; Rats, Wistar; Safflower Oil | 2001 |
Relationship of triglycerides and HDL cholesterol in hypertriglyceridemia.
Topics: Adult; Aged; Bezafibrate; Cholesterol, HDL; Combined Modality Therapy; Female; Humans; Hypertriglyceridemia; Hypolipoproteinemias; Lipoproteins, HDL; Male; Middle Aged; Triglycerides | 1992 |
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.
Topics: Adult; Bezafibrate; Biological Transport; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Glycoproteins; Humans; Hypertriglyceridemia; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Triglycerides | 1991 |
Cyclosporin-induced hypertriglyceridemia with prompt response to plasma exchange therapy.
Topics: Adolescent; Bezafibrate; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Humans; Hypertriglyceridemia; Immunoglobulins, Intravenous; Plasma Exchange; Postoperative Complications; Prednisone | 1991 |
Sustained-release bezafibrate corrects lipid abnormalities in patients on continuous ambulatory peritoneal dialysis.
Topics: Adolescent; Adult; Aged; Bezafibrate; Cholesterol, HDL; Coronary Disease; Delayed-Action Preparations; Diabetes Complications; Drug Evaluation; Female; Humans; Hypertriglyceridemia; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Muscular Diseases; Peritoneal Dialysis, Continuous Ambulatory | 1990 |
Interruption of long-term lipid-lowering treatment with bezafibrate in hypertriglyceridaemic patients. Effects on lipoprotein composition, lipase activities and the plasma lipid fatty acid spectrum.
Topics: Aged; Apolipoproteins B; Bezafibrate; Cholesterol; Female; Humans; Hypertriglyceridemia; Lipoprotein Lipase; Lipoproteins, VLDL; Male; Middle Aged; Time Factors; Triglycerides | 1990 |
Modification of low density lipoproteins from hypertriglyceridemic patients by macrophages in vitro and the effect of bezafibrate treatment.
Topics: Adult; Bezafibrate; Cholesterol; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; In Vitro Techniques; Lipoproteins, LDL; Macrophages; Male; Middle Aged; Vitamin E | 1989 |